Publikasjoner
Vitenskapelig artikkel
- Titas Gladkauskas; Ileana Cristea; Roya Mehrasa et al. (2025). Recurrent platelet-derived growth factor receptor beta gene mutations in Kosaki overgrowth syndrome: a molecular and clinical overview. (ekstern lenke)
- Ileana Cristea; Roya Mehrasa; Titas Gladkauskas et al. (2025). Variable response of germline activating PDGFRB variants to receptor tyrosine kinase inhibitors: implications for treatment. (ekstern lenke)
- Cecilie Bredrup; Ileana Cristea; Leen Abu Safieh et al. (2021). Temperature-dependent autoactivation associated with clinical variability of PDGFRB Asn666 substitutions. (ekstern lenke)
- Ileana Cristea; Ove Bruland; Ingvild Aukrust et al. (2021). Pellino-2 in nonimmune cells: novel interaction partners and intracellular localization. (ekstern lenke)
- Ileana Cristea; Hugo Abarca; Anne Elisabeth Christensen et al. (2023). A Pellino-2 variant is associated with constitutive NLRP3 inflammasome activation in a family with ocular pterygium–digital keloid dysplasia. (ekstern lenke)
- Roya Mehrasa; Ileana Cristea; Cecilie Bredrup et al. (2023). Functional characterization of all-trans retinoic acid-induced differentiation factor (ATRAID). (ekstern lenke)
- Ileana Cristea; Ove Bruland; Eyvind Rødahl et al. (2021). K+ regulates relocation of Pellino-2 to the site of NLRP3 inflammasome activation in macrophages. (ekstern lenke)
- Titas Gladkauskas; Ileana Cristea; Roya Mehrasa et al. (2025). Temperature as a Key Modulator: Investigating Phosphorylation Patterns of p.Asn666 PDGFRB Variants and Their Role in Downstream Signaling. (ekstern lenke)
- Anne Elisabeth Christensen; Ileana Cristea; Thomas Michael James Stevenson et al. (2025). On subcellular distribution of the zinc finger 469 protein (ZNF469) and observed discrepancy in the localization of endogenous and overexpressed ZNF469. (ekstern lenke)
- Titas Gladkauskas; Ida Marie Rundgren; Ileana Cristea et al. (2025). Treatment Options for Alkali Burn-Induced Corneal Neovascularization: A Comparative Analysis of Two Tyrosine Kinase Inhibitors. (ekstern lenke)
- Cecilie Bredrup; Tomasz Stokowy; Julie McGaughran et al. (2018). A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome.. (ekstern lenke)
- Linda Zi Yan Xu; Hanne Jensen; Jennifer Johnston et al. (2018). Recurrent, activating variants in the receptor tyrosine kinase DDR2 cause Warburg-Cinotti syndrome. (ekstern lenke)